At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multimodal Imaging of Progesterone/Neurosteroid Effects in Nicotine Addiction
In Brief
A Phase 4 clinical trial evaluating Progesterone and Placebo for Nicotine Dependence and Nicotine Withdrawal. Completed, enrolled 81 participants across 1 site.
Detailed Summary
Male and female smokers were recruited to undergo 2 phases of smoking cessation. Each phase was 4 days long and involved 3 brain-imaging scans, blood draws and an intervention involving progesterone or a matched placebo.
Study Details
Timeline
Interventions
Participants will consume four pills of Progesterone over a period of four days. Participants will be asked to remain abstinent from smoking while taking Progesterone.
Participants will consume four pills of Placebo over a period of four days. Participants will be asked to remain abstinent from smoking while taking Placebo.